The GLP-1 Nutrition Coaching Market is projected to rise from USD 124.8 million in 2026 to USD 680.0 million by 2036 at an 18.5% CAGR.
ROCKVILLE, MD — October 6, 2026 — The GLP-1 Nutrition Coaching Market is projected to reach USD 680.0 million by 2036, increasing from USD 124.8 million in 2026 at an 18.5% CAGR, according to Fact.MR. The market reached USD 105.3 million in 2025 as GLP-1 medication users and sponsors began seeking structured nutrition support.
The market is expected to add USD 555.2 million in absolute opportunity by 2036. Appetite changes, reduced meal sizes, nutrition-related side effects, and weight-maintenance needs are shaping demand for services that connect nutrition guidance with GLP-1 treatment.
The reason for the growth is direct. Users may eat less while taking GLP-1 medicines, making protein intake and overall diet quality harder to maintain. Employers and health plans are also evaluating services that can support safer treatment use beyond the prescription itself.
Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=15700
GLP-1 Nutrition Coaching Market: Key Segments
Registered dietitian-led coaching is expected to account for 38.3% of the market in 2026, making it the leading coaching model. Licensed dietitians can adjust meal guidance when appetite changes, digestive symptoms, or medication changes affect food intake.
Protein & muscle preservation is projected to hold 40.8% share in 2026, the highest share among nutrition-focus categories. Lower food intake during rapid weight loss can make protein planning more relevant to maintaining lean tissue and strength.
Mobile apps are anticipated to capture 37.4% share in 2026. App-based services allow users to review meal plans, record symptoms, track progress, and communicate with coaches between scheduled sessions.
Employers are estimated to represent 36.2% share in 2026. Employer-funded programs can connect GLP-1 access with nutrition coaching and wider weight-management benefits while keeping treatment support within a structured program.
Fact block: Fact.MR is a market research organization that provides market sizing, forecasting, segment analysis, and competitive intelligence across global industries.
Why Nutrition Support Is Becoming More Relevant
GLP-1 users can experience lower appetite, nausea, or constipation, all of which may alter normal eating patterns. The market analysis identifies the need to preserve lean mass and nutrition-related side effects as high-impact, short-term drivers globally.
Wraparound obesity care carries a medium impact over the medium term. Employer and payer interest also carries medium impact, particularly in the USA and enterprise markets.
At the same time, qualified dietitian shortages remain a high-impact restraint globally. Unclear boundaries between nutrition support and medical care are another high-impact concern in regulated and payer-funded markets.
“GLP-1 nutrition coaching has to prove that lower appetite does not reduce diet quality,” said Shambhu Nath Jha, Sr. Consultant at Fact.MR. “Commercial acceptance is expected to depend on dietitian access, escalation rules and maintenance support after early weight loss slows.”
Digital Delivery Expands Access
Technology is changing how nutrition professionals deliver support. AI-assisted preparation and asynchronous messaging can reduce administrative work, allowing dietitians to spend more time on complex cases and escalation decisions.
Hybrid RD plus AI models are included in the market scope. Group coaching also provides a lower-cost option for users who mainly need education and accountability.
Mobile applications remain central because food decisions happen throughout the day. Video consultations support detailed clinical review, while asynchronous messaging allows users to ask questions without waiting for another appointment.
The report also identifies maintenance coaching as a medium-term opportunity. Support after dose reduction or discontinuation may become more relevant as appetite returns and users move beyond early weight loss.
USA Leads Country Growth
The USA is forecast to grow at an 18.7% CAGR from 2026 to 2036, the highest rate among the five profiled countries. Employer benefit design and virtual dietitian access are key factors supporting adoption.
The UK is projected to record an 18.3% CAGR, while Germany is expected to grow at 18.0%. Canada follows at 17.7%, and Australia is forecast at 17.4%.
The 1.30-percentage-point spread between the USA and Australia shows that comparable demand does not produce identical market conditions. Benefit design, reimbursement structures, privacy requirements, professional access, and remote-care infrastructure influence deployment across countries.
The World Health Organization issued its global guideline on the use of GLP-1 medicines in treating obesity on December 1, 2025, providing an authoritative reference point for the broader treatment environment.
Competitive Landscape
Key companies profiled in the GLP-1 Nutrition Coaching Market include Nourish, Fay Nutrition, Season Health, Noom, Berry Street, and Culina Health.
Nourish and Fay Nutrition have a direct nutrition-care focus through registered dietitian access and virtual nutrition counseling. Season Health contributes a food-as-medicine model, while Berry Street and Culina Health extend access through licensed dietitian networks and insurance-connected nutrition therapy.
Noom strengthens the broader behavior-change and GLP-1 companion segment.
Fact.MR’s analysis draws on 120+ sources, 35+ company portfolios, 25+ countries, and more than 20 industry interviews. The assessment combines primary research with government statistics, regulatory publications, company filings, trade data, technical studies, industry associations, and other documented sources.
“Dietitian access is going to matter,” said Shambhu Nath Jha, Sr. Consultant at Fact.MR. “The market also needs clear escalation rules and maintenance support when early weight loss slows.”
View Related Reports :
About Fact.MR
Fact.MR is a market research and consulting company providing market intelligence, forecasting, competitive analysis, and strategic research across global industries. Its research combines primary interviews, secondary research, market sizing, segment analysis, and country-level assessment to evaluate changing commercial conditions.
